Treatment of prostate cancer with gonadotropin-releasing hormone analogue: Effect on lipoprotein[a]

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 7, 1996, Pages 2508-2511

  Arrer, E ^a   Jungwirth, A ^a   Mack, D ^a   Frick, J ^a   Patsch, W ^a  

^a Salzburger Landeskliniken   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; BUSERELIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CORONARY RISK; DRUG EFFECT; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

AGED; APOLIPOPROTEINS B; BUSERELIN; HUMANS; LIPIDS; LIPOPROTEIN(A); MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TESTOSTERONE;

EID: 0029955233     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.7.2508     Document Type: Article

References (33)

1. Dahlen G, Berg K, Gillnas T, Ericson C. 1975 Lp(a) lipoprotein pre-beta1-lipoprotein in Swedish middle-aged males and in patients with coronary heart disease. Clin Genet. 7:334-341.
2. Rhoads GG, Dahlen G, Berg K, Morton NE, Dannenberg AL. 1986 Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA. 256:2540-2544.
3. Armstrong VW, Cremer P, Eberle E, et al. 1986 The association between serum Lp[a] concentrations and angiographically assessed coronary atherosclerosis: dependence on serum LDL levels. Atherosclerosis. 62:249-257.
4. Schreiner PJ, Morrisett JD, Sharrett AR, et al. 1993 Lipoprotein [a] as a risk factor for preclinical atherosclerosis. Arterioscler Thromb. 13:826-833.
5. Brown SA, Morrisett JD, Boerwinkle E, Hutchinson E, Patsch W. 1993 The relation of lipoprotein [a] concentrations and apolipoprotein [a] phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb. 13:1558-1566.
6. Gaubatz JW, Heideman C, Gotto Jr AM, Morrisett JD, Dahlen GH. 1983 Human plasma lipoproteinlal. Structural properties. J Biol Chem. 258:4582-4589.
7. Bersot PT, Innerarity TL, Pitas RE, Rall Jr SC, Weisgraber KH, Mahley RW. 1986 Fat loading in humans induces lipoproteins of density less than 1.006 that are enriched in apolipoprotein [a] and that cause lipid accumulation in macrophages. J Clin Invest. 77:622-630.
8. Patsch W, Brown SA, Morrisett JD, Gotto Jr AM, Patsch JR, 1989 A dual-precipitation method evaluated for measurement of cholesterol in high density lipoprotein subfractions HDL2 and HDL3 in human plasma. Clin Chem. 35:265-270.
9. Utermann G. 1990 The mysteries of lipoprotein[a]. Science. 246:904-910.
10. McLean JW, Tomlinson JE, Kuang W, et al. 1987 cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature. 330:132-137.
11. Lackner C, Boerwinkle E, Leffert CC, Rahmig T, Hobbs HH. 1991 Molecular basis of apolipoprotein(a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J Clin Invest. 87:2077-2086.
12. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH. 1992 Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest. 90:52-60.
13. Bruckert E, Davidoff P, Grimaldi A, et al. 1990 Increased serum levels of lipoprotein(a) in diabetes mellitus and their reduction with glycemic control. JAMA. 263:35-36.
14. Parra HJ, Mezdour H, Cachera C, Dracon M, Tacquet A, Fruchart JC. 1987 Lp(a) lipoprotein in patients with chronic renal failure treated by hemodialysis. Clin Chem. 33:721.
15. Maeda S, Abe A, Seishima M, Makino K, Noma A, Kawade M. 1989 Transient changes of serum lipoprotein(a) as an acute phase protein. Atherosclerosis. 89:145-150.
16. Farmer JA, Ballantyne CM, Frazier OH, et al. 1991 Lipoprotein(a) and apolipoprotein changes after cardiac transplantation. J Am Coll Cardiol. 18:926-930.
17. Wade DP, Clarke JG, Lindahl GE, et al. 1993 5′ Control regions of the apolipoprotein (a) gene and members of the related plasminogen gene family. Proc Natl Acad Sci USA. 90:1369-1373.
18. Brown SA, Hutchinson R, Morrisett J, et al. 1993 Serum lipid, lipoprotein cholesterol and apoprotein distributions in selected US communities. The Athersclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb. 134:1139-1158.
19. Sandkamp M, Assmann G. 1990 Lipoprotein(a) in PROCAM participants and young myocardial infarction survivors. In: Scanu AM, ed. Lipoprotein(a): 25 years of progress. New York: Academic Press; 205-209.
20. Jenner JL, Ordovas JM, Lamon-Fava S, et al. 1993 Effects of age, sex, and menopausal status on plasma lipoprotein (a) levels. The Framingham Offspring Study. Circulation. 87:1135-1141.
21. Nabulsi AA, Folsom AR, White A, et al 1993 Association of hormone replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med. 328:1069-1075.
22. Henriksson P, Angelin B, Berglund L. 1992 Hormonal regulation of serum Lp(a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma. J Clin Invest. 89:1166-1171.
23. Friedewald WT, Levy RI, Fredrickson DS. 1972 Estimation of the concentration of low-density lipoprotein in serum, without use of the preparative ultracentrifuge. Clin Chem. 18:499-502.
24. Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C. 1987 Lp[a] glycoprotein phenotypes. Inheritance and relation to Lp[a]-lipoprotein concentrations in plasma. J Clin Invest. 80:458-465.
25. Moorjani S, Dupont A, Labrie F, et al. 1988 Changes in plasma lipoproteins during various androgen suppression therapies in men with prostatic carcinoma: effects of orchiectomy, estrogen, and combination treatment with luteinizing hormone-releasing hormone agonist and flutamide. J Clin Endocrinol Metab. 66:314-322.
26. Hofmann SA, Eaton DL, Brown MS, McConathy WJ, Goldstein JL, Hammer RL. 1990 Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp[a] lipoprotein in transgenic mice. J Clin Invest. 85:1542-1547.
27. Rader DJ, Mann WA, Cain W, et al. 1995 The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans. J Clin Invest. 95:1403-1408.
28. Krempler F, Kostner GM, Bolzano K, Sandhofer F. 1980 Turnover of lipoprotein (a) in man. J Clin Invest. 65:1483-1490.
29. Azrolan N, Gavish D, Breslow JL. 1991 Plasma lipoprotein(a) concentration is controlled by apolipoprotein(a) [apo(a)] protein size and the abundance of hepatic apo(a) mRNA in a cynomolgus monkey model. J Biol Chem. 266:13866-13872.
30. White AL, Hixson JE, Rainwater DL, Lanford RE. 1994 Molecular basis for 'null' lipoprotein(a) phenotypes and the influence of apolipoprotein(a) size on plasma lipoprotein(a) level in the baboon. J Biol Chem. 269:9060-9066.
31. White AL, Rainwater DL, Lanford RE. 1993 Intracellular maturation of apolipoprotein(a) and assembly of lipoprotein(a) in primary baboon hepatocytes. J Lipid Res. 34:509-517.
32. Byar DP, Corle DK. 1988 Hormone therapy for prostate cancer: results of the Veterans Administration Cooperative Urological Research Group studies. In: Wittes RE, ed. Consensus Development Conference on the Mangement of Clinically Localized Prostate Cancer. NCI monogr 7. NIH publication 88-3005. Washington DC: U.S. Government Printing Office; 165-170.
33. Parmar H, Phillips RH, Lightman SL, Edwards L, Allen L, Schally AV. 1985 Randomised controlled study of orchidectomy vs long-acting D-Trp-6-LHRH microcapsules in advanced prostatic carcinoma. Lancet. 2:1201-1205.